| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |